Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, November 21, 2017

Public edition | newswise.com

Newswise Cancer Research Wire for 21-Nov-2017
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



Preclinical Study Demonstrates Promising Treatment for Rare Bone Disease

Researchers have demonstrated that the drug palovarotene suppresses the formation of bony tumors (osteochondromas) in models of multiple hereditary exostoses (MHE). The research, published in the Journal of Bone and Mineral Research, is an important ...

– Sanford Burnham Prebys Medical Discovery Institute

Journal of Bone and Mineral Research; R01AR055670


Climbing Costs for Treating Breast Cancer Poised to Strain Medicare in the Near Future

New study in JNCCN calls for more planning and research to prepare for the increasing financial burden of treating breast cancer.

– National Comprehensive Cancer Network® (NCCN®)

Journal of the National Comprehensive Cancer Network


Some Cancer Therapies May Provide a New Way to Treat High Blood Pressure

Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment because although a number...

– Georgetown University Medical Center

Hypertension

Embargo expired on 20-Nov-2017 at 05:00 ET


Pairing Cancer Genomics with Cognitive Computing Highlights Potential Therapeutic Options

UNC researchers use cognitive computing to scour large volumes of data from scientific studies and databases to find potentially relevant clinical trials or therapeutic options for cancer patients based on the genetics of their tumors.

– University of North Carolina Health Care

The Oncologist

Embargo expired on 20-Nov-2017 at 09:00 ET


New Approach to Studying Chromosomes’ Centers May Reveal Link to Down Syndrome and More

A PCR-based approach to a frontier of the human genome -- the centromere -- could speed discovery in chromosome-based diseases and birth defects.

– Michigan Medicine - University of Michigan

Genome Research, Early online publication


How a Poorly Explored Immune Cell May Impact Cancer Immunity and Immunotherapy

The immune cells that are trained to fight off the body’s invaders can become defective. It’s what allows cancer to develop. So most research has targeted these co-called effector T-cells. But a new study takes a step back and considers: What if ...

– Michigan Medicine - University of Michigan

Science Immunology; CA217510; CA123088; CA099985; CA156685; CA171306; CA190176; CA193136; 5P30CA46592

Embargo expired on 17-Nov-2017 at 14:00 ET


Helping Cancer Patients Quit Tobacco for Good

A new treatment program that combines the power of technology with tried and true methods to help cancer patients overcome their addiction to tobacco is ready to enroll its first patients at Penn Medicine’s Abramson Cancer Center. As part of the pr...

– Perelman School of Medicine at the University of Pennsylvania

Embargo expired on 16-Nov-2017 at 06:00 ET


Computer Program Finds New Uses for Old Drugs

Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about F...

– Case Western Reserve University

Oncogene; Norma C. and Albert I. Geller via the Gynecological Cancer Translation Research Program at the Case Comprehensive Cancer Center; The Mary Kay Foundation; The Young Scientist Foundation...


AACI Rejects Administration’s Proposal to Cut Reimbursement to Cancer Hospitals

The Association of American Cancer Institutes opposes the Centers for Medicare and Medicaid Services Medicare Programs: Hospital Outpatient Prospective Payment Systems rule, which threatens access to lifesaving treatments for uninsured and underserve...

– Association of American Cancer Institutes (AACI)


Seattle Children's Opens First CAR T-Cell Immunotherapy Trial in the U.S. for Children and Young Adults With Leukemia that Targets CD22 and CD19 Proteins Simultaneously

Seattle Children’s has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the U.S. for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia (ALL) that will simultaneo...

– Seattle Children's Hospital


Wider Sampling of Tumor Tissues May Guide Drug Choice, Improve Outcomes

By focusing on genetic variations within a primary tumor, differences between the primary and a metastatic tumor, and additional diversity from tumor DNA in the blood stream, physicians can make better treatment choices for patients with gastric and ...

– University of Chicago Medical Center

Cancer Discovery


Rep. Jamie Raskin Joins Fight Colorectal Cancer’s Congressional Committee

Representative Jaime Raskin (D-MD) joins Fight Colorectal Cancer's Congressional Committee to advocate for CRC patients from the Hill. Raskin is a stage III survivor.

– Fight Colorectal Cancer


This Is Why Testicular Cancer Is So Responsive to Chemo

Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?

– Cornell University

Cell Reports

Embargo expired on 14-Nov-2017 at 12:00 ET


Deadly Lung Cancers Are Driven by Multiple Genetic Changes

A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant “driver” mutation that can be treated in isolation with a single targeted drug.

– UCSF Helen Diller Family Comprehensive Cancer Center

Nature Genetics


Study: Process Used to Select Lung Transplant Patients May Need to Be Changed

New research from the University of Maryland School of Medicine suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long a person might survive without a lung transplant an...

– University of Maryland Medical Center/School of Medicine

Chest


Lung Cancer Awareness Saves Lives

Lung cancer is the second most common cancer in both men and women. It is a preventable disease as 80 percent of lung cancer deaths are thought to result from smoking. An expert from Rutgers Cancer Institute of New Jersey notes awareness and a tobacc...

Expert Available

– Rutgers Cancer Institute of New Jersey


Policy and Public Affairs


Editorial: Use Big Tobacco’s Nov 26 Corrective Statements to Reduce Smoking

The court-ordered publication of “corrective statements” by major U.S. tobacco companies later this month should serve as a reminder that tobacco addiction remains a major health problem in the country and that Big Tobacco has a long history of m...

– American Thoracic Society (ATS)

Annals of the American Thoracic Society


Announcements


The Leukemia & Lymphoma Society Awards Grant to Savoldo for Immunotherapy Research

A grant from The Leukemia & Lymphoma Society will help fund clinical research led by UNC Lineberger's Barbara Savoldo, MD, PhD, into an investigational chimeric antigen receptor (CAR) T-cell treatment for acute lymphoblastic leukemia that would inclu...

– University of North Carolina Health Care System


ALCEA ADVISORS, the Reference Partner for Oncology Startups in Europe, Welcomes Dr. Henri Chaoul as a Member of Its Investment Committee

ALCEA ADVISORS, the reference partner for oncology startups in Europe, welcomes Dr. Henri Chaoul as a Member of its Investment Committee

– ALCEA ADVISORS


ALCEA ADVISORS, the Reference Partner for Oncology Startups in Europe, Welcomes Dr. Steve Arlington as a Member of Its Investment Committee

ALCEA ADVISORS, the reference partner for oncology startups in Europe, welcomes Dr. Steve Arlington as a Member of its Investment Committee

– ALCEA ADVISORS


Six Researchers From MD Anderson Elected as AAAS Fellows

In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS)...

– University of Texas M. D. Anderson Cancer Center

Embargo expired on 20-Nov-2017 at 05:00 ET


Study to Examine How Tumor Necrosis Factor Works to Reduce Intestinal Inflammation

An investigator at Children’s Hospital Los Angeles, has been awarded $1.5 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH for the study of tumor necrosis factor (TNF) and its role in inflammatory bowel dis...

– Children's Hospital Los Angeles Saban Research Institute

R01DK056008


Rutgers Cancer Institute of New Jersey, Rutgers Health and University Hospital Unite with the American Cancer Society in the Fight Against Colorectal Cancer

Rutgers Cancer Institute of New Jersey, Rutgers Health, and University Hospital have committed to increasing colorectal cancer screening across New Jersey by joining a national effort with the American Cancer Society in the fight against this disease...

– Rutgers Cancer Institute of New Jersey


Penn Medicine’s Anil K. Rustgi and Hongzhe Li Named 2017 AAAS Fellows

  PHILADELPHIA—Anil K. Rustgi, MD, chief of the division of Gastroenterology and T. Grier Miller Professor of Medicine and Genetics, and Hongzhe Li, PhD, a professor of biostatistics in Biostatistics and Epidemiology, both at the Perelman School o...

– Perelman School of Medicine at the University of Pennsylvania


NCCN, in Collaboration with Pfizer, Awards Nine Grants for Quality Improvement in Breast Cancer Care

NCCN and Pfizer announce funding for projects evaluating different clinical care pathways to improve breast cancer care, with a particular emphasis on underserved patients.

– National Comprehensive Cancer Network® (NCCN®)


Society of Vascular and Interventional Neurology (SVIN) presents Neurologist Pioneering Award to Dr. Anthony Furlan

Dr. Anthony Furlan of University Hospitals in Cleveland was given the Neurologist Pioneering Award from the Society of Vascular and Interventional Neurology (SVIN).

– University Hospitals Cleveland Medical Center


Irving Family’s $700 Million Bequest to Columbia University and NewYork-Presbyterian Sets Stage for Dramatic Advances in Cancer Research and Care

Columbia University and NewYork-Presbyterian announced today that Florence Irving and her late husband, Herbert Irving, have given $700 million to the two institutions to dramatically advance research and clinical programs for the treatment of cancer...

– New York-Presbyterian Hospital


Seattle Children’s Launches $1 Billion Fundraising Campaign to Transform Children’s Health

Seattle Children’s today launched a $1 billion initiative, It Starts With Yes: The Campaign for Seattle Children’s, with a bold vision: to transform children’s health. It Starts With Yes is the largest campaign in Seattle Children’s 110-year ...

– Seattle Children's Hospital


MSK-IMPACT™ Is the First Tumor-Profiling Multiplex Panel Authorized by the FDA, Setting a New Pathway to Market for Future Oncopanels

The US Food and Drug Administration (FDA) announced today the authorization of MSK-IMPACT™ (which stands for integrated mutation profiling of actionable cancer targets), a high throughput, targeted-DNA-sequencing panel for somatic mutations. Create...

– Memorial Sloan Kettering Cancer Center


Hospital Throws Turkey Day Party for Survivors, Kids with Cancer

The Children’s Hospital University of Illinois will host a pre-holiday Thanksgiving meal and celebration for pediatric cancer patients and their families Nov. 18.

– University of Illinois at Chicago


Expert Pitch


Throat Cancer Experts Available for Comment/Background Related to Beth Chapman/Dog the Bounty Hunter Special

– American Society for Radiation Oncology (ASTRO)


Tobacco Companies to Admit to Deceiving Public About Smoking’s Health Risks

– American Thoracic Society (ATS)

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 Michigan Medicine - University of Michigan

 Seattle Children's Hospital

 American Thoracic Society (ATS)

 University of Texas M. D. Anderson Cancer Center


Subscribe / Unsubscribe
Edit my preferences

© 2017 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us